1-(3-tert-butylphenyl)-3-[5-[2-[2-(2-oxopropyl)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]propan-2-one
C26H30N2O2S — CID 158544167
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3-tert-butylphenyl)-3-[5-[2-[2-(2-oxopropyl)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]propan-2-one
1-(3-tert-butylphenyl)-3-[5-[2-[2-(2-oxopropyl)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]propan-2-one (PubChem CID 158544167) has the molecular formula C26H30N2O2S and a molecular weight of 434.61 g/mol. Its IUPAC name is 1-(3-tert-butylphenyl)-3-[5-[2-[2-(2-oxopropyl)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]propan-2-one.
Molecular Properties
| Compound Name | 1-(3-tert-butylphenyl)-3-[5-[2-[2-(2-oxopropyl)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]propan-2-one |
|---|---|
| PubChem CID | 158544167 |
| Molecular Formula | C26H30N2O2S |
| Molecular Weight | 434.61 g/mol |
| Exact Mass | 434.20 |
| IUPAC Name | 1-(3-tert-butylphenyl)-3-[5-[2-[2-(2-oxopropyl)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]propan-2-one |
| SMILES | CC(=O)Cc1cc(CCc2cnc(CC(=O)Cc3cccc(C(C)(C)C)c3)s2)ccn1 |
| InChI | InChI=1S/C26H30N2O2S/c1-18(29)12-22-14-19(10-11-27-22)8-9-24-17-28-25(31-24)16-23(30)15-20-6-5-7-21(13-20)26(2,3)4/h5-7,10-11,13-14,17H,8-9,12,15-16H2,1-4H3 |
| InChIKey | HOWWTCZTTMPWFV-UHFFFAOYSA-N |
| XLogP | 5.11 |
| TPSA | 59.92 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.61 |
| LogP ≤ 5 | 5.11 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158544167 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.